WWW.KONF.X-PDF.RU
- , ,
 


Pages:     | 1 |   ...   | 3 | 4 ||

, ...

-- [ 5 ] --

208. Telenti, A. Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis / A. Telenti, P. Imboden, F. Marchesi, T. Schmidheini, T. Bodmer // Antimicrob. Agents Chemother. 1993. Vol. 37. P. 2054 2058.

209. Telenti, A. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis / A. Telenti, P. Imboden, F. Marchesi et al. // Lancet. 1993. Vol. 341. P. 647-650.

210. Telenti, A. The emb operon, a unique gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol / A. Telenti, W.J. Philipp, S. Sreevatsan et al. // Nature Med. 1997. Vol. 3. P. 567-570.

211. Tortoli, E. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis / E. Tortoli, C. Russo, C. Piersimoni et al. // European Respiratory Journal. 2012. Vol. 40 (2). P. 442447.

212. van Deun, A. Evaluation of tuberculosis control by periodic or routine susceptibility testing in previously treated cases / A. van Deun, A. Salim, L.

Rigouts et al. // Int. J. Tuberc. Lung Dis. 2001. Vol. 5. N. 4. P. 329-338.

213. van Helden, P. Bacterial genetics and strain variation / P. van Helden // Novartis Found Symp. 1998. N. 217. P. 78-90.

214. Varaine, F. Tuberculosis. Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries / F. Varaine, M.L. Rich // Medecins Sans Frontiere. 2013. C. 37-38.

215. Vareldzis, B.P. Drug resistant tuberculosis: laboratory issues, World Health recommendations / B.P. Vareldzis, T. Grosset, I. de Kantor et. al. // Tuberc.

Lung. Dis. 1994. Vol. 75 (1). P. 1-7.

216. Verbist, L. Antituberculosis activity of rifampin in vitro and in vivo and the concentrations attained in human blood / L. Verbist, A. Gyselen // Am. Rev.

Respir. Dis. 1968. Vol. 98. P. 923-932.

217. Vilcheze, C. Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis / C. Vilcheze, Y. Av-Gay, R.

Attarian et al. // Mol. Microbiol. 2008. Vol. 69. P. 1316-1329.

218. Viljanen, M.K. Survey of drug-resistant tuberculosis in northwestern Russia from 1984 through 1994 / M.K. Viljanen, B.L Vyshnevskiy, T.F. Otten // Ear.

J. Clin.Microbiol. Infect. Dis. 1998. Vol. 17. P. 177-183.

219. Wade, M.M. Mechanisms of drug resistance in Mycobacterium tuberculosis / M.M. Wade, Y. Zhang // Front. Biosci. 2004. Vol. N. 9. P. 975-994.

220. Wang, J.Y. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates:

associated genetic mutations and relationship to antimicrobial exposure / J.Y.

Wang, L.N. Lee, H.C. Lai et al. // J. Antimicrob. Agents Chemother. 2007. Vol. 59. P. 860-865.

221. WHO. Report on TB epidemic. Global TB programme // WHO, Geneva. 1997.

222. WHO. Geneva/IUATLD Paris. Guidelines for surveillance of drug resistance in tuberculosis //Int. J. Tuberc. Lung. Dis. 1998. N. 22. P. 72-89.

223. WHO/IUATLD. Anti-tuberculosis drug resistance in the world: the WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance 1994-1997 // WHO. Geneva, 1998.

224. WHO/IUATLD Anti-tuberculosis drug resistance in the world: the WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Report 3. Geneva, World Health Organization, 2005.

225. Williams, D.L. Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis / D.L. Williams, L. Spring, L.

Collins et al. // Antimicrob. Agents Chemother. 1998. Vol. 42. P. 1853Wolucka, B. Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria / B. Wolucka, M. McNeil, E. de Hoffmann et al. // J. Biol. Chem. 1994. Vol. 269. P. 23328-23335.

227. Yew, W.W. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens / W.W.

Yew, C.K. Chan, C.H. Chau et al. // Chest. 2000. N. 117. P. 744-751.

228. Yuen, L. Bacteriological and molecular analysis of rifampin-resistant M.

tuberculosis strains isolated in Australia / L. Yuen, D. Leslie, P. Coloe // J.

Clin. Micribiol. 1999. Vol. 37 N. 12. P. 3844-3850.

229. Zhang Y. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis / Y. Zhang, B. Heym, B. Allen et al. // Nature. 1992. Vol. 358. P. 591-593.

230. Zhang Y. Genetics of drug resistance in Mycobacterium tuberculosis / Y.

Zhang, A. Telenti // Hatfull G. Jacobs W.R et al. Molecular genetics of mycobacteria. Washington DC, USA: ASM Press, 2000. P. 235-254.



Pages:     | 1 |   ...   | 3 | 4 ||

:

( CLETHRIONOMYS) - 03.02.08 : .. 2015 .. 1. ...

14.01.07 : 2015...

03.02.08 : , 2014 . 1. 1.1 ...

- 14.03.09 14.01.03 , : ...

: 5+59+634.9 (LEPIDOPTERA) (SARROTHRIPUS MUSCULANA ERSSCH) (HYPONOMENTA MALINELUSUS SELL) 06.01.07 : .. ...

A(H1N1) pdm09, 2009 2013 . 03.02.02 .. - ..5...

03.03.04 , , .....







 
<<     |    
2016 www.konf.x-pdf.ru - - , ,

, .
, , , , 1-2 .